Literature DB >> 24023590

Long term Anticoagulation at Crossroads.

Mircea Cinteza1.   

Abstract

Year:  2013        PMID： 24023590      PMCID： PMC3749757     

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN： 1841-9038


× No keyword cloud information.
  8 in total

Review 1.  New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Jeffrey I Weitz; John W Eikelboom; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.

Authors:  Corey S Miller; Sonia M Grandi; Avi Shimony; Kristian B Filion; Mark J Eisenberg
Journal:  Am J Cardiol       Date:  2012-04-24       Impact factor: 2.778

3.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

Review 4.  Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Authors:  Cecilia Becattini; Maria Cristina Vedovati; Giancarlo Agnelli
Journal:  Thromb Res       Date:  2012-01-20       Impact factor: 3.944

5.  Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

Authors:  Sam Schulman; Clive Kearon; Ajay K Kakkar; Sebastian Schellong; Henry Eriksson; David Baanstra; Anne Mathilde Kvamme; Jeffrey Friedman; Patrick Mismetti; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

6.  New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis.

Authors:  I Lisanne Holster; Vera E Valkhoff; Ernst J Kuipers; Eric T T L Tjwa
Journal:  Gastroenterology       Date:  2013-03-05       Impact factor: 22.682

7.  Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials.

Authors:  Benjamin D Fox; Susan R Kahn; David Langleben; Mark J Eisenberg; Avi Shimony
Journal:  BMJ       Date:  2012-11-13

Review 8.  New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis.

Authors:  Jonas Oldgren; Lars Wallentin; John H Alexander; Stefan James; Birgitta Jönelid; Gabriel Steg; Johan Sundström
Journal:  Eur Heart J       Date:  2013-03-06       Impact factor: 29.983
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.